Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Immune Checkpoint Inhibitors × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Solid Cancers 2 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Skin Neoplasms 1 Sarcopenia 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 SCLC 1 Rhabdomyosarcoma 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neoadjuvant Therapies 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡